Synthesis of C‐3‐Functionalized Imidazo[1,2‐ a ]pyridines via Direct para ‐Position Arylation of Electron‐Rich Anilines under Transition‐Metal‐Free Conditions
Advanced Synthesis & Catalysis · 04.07.2023 · 365 (13) · 2159-2164
DOI: 10.1002/adsc.202300347 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Synthesis & Catalysis, online erschienen am 23.06.2023. Verfasst von Liqiang Hao und 4 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
A multicomponent tandem arylation reaction was established under transition‐metal‐free conditions to synthesize structurally diverse imidazo[1,2‐ a ]pyridines. As N,N ‐dimethylaniline is not only a reactant but also a methylation reagent, its use affords an alternative route for methylation. This approach features mild reaction conditions and good functional group tolerance, providing 29 compounds in acceptable yields.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Hao, L., Wu, G., Wang, Y., Xu, X., & Ji, Y. (2023). Synthesis of C‐3‐Functionalized Imidazo[1,2‐ a ]pyridines via Direct para ‐Position Arylation of Electron‐Rich Anilines under Transition‐Metal‐Free Conditions. Advanced Synthesis & Catalysis, 365(13), 2159-2164. https://doi.org/10.1002/adsc.202300347
Vancouver
Hao L, Wu G, Wang Y, Xu X, Ji Y. Synthesis of C‐3‐Functionalized Imidazo[1,2‐ a ]pyridines via Direct para ‐Position Arylation of Electron‐Rich Anilines under Transition‐Metal‐Free Conditions. Advanced Synthesis & Catalysis. 2023;365(13):2159-2164. doi:10.1002/adsc.202300347
BibTeX
@article{Hao2023,
author = {Hao, Liqiang and Wu, Gaorong and Wang, Yangyang and Xu, Xiaobo and Ji, Yafei},
title = {Synthesis of C‐3‐Functionalized Imidazo[1,2‐ a ]pyridines via Direct para ‐Position Arylation of Electron‐Rich Anilines under Transition‐Metal‐Free Conditions},
journal = {Advanced Synthesis & Catalysis},
year = {2023},
volume = {365},
number = {13},
pages = {2159--2164},
doi = {10.1002/adsc.202300347}
}
EUVIMED